Abstract
Discriminative stimulus control was established in rats (N=12) with LSD (100 μg/kg) and saline using a two-lever response choice task and an FR10 schedule of water reinforcement. Subjects were then tested once per week with either LSD or quipazine (3 mg/kg) and every other week the test ratio was doubled, i.e., each drug was tested at ratios of 10, 20, 40, and 80. In contrast with LSD, which maintained stimulus control at all ratios, LSD-appropriate responding following quipazine declined significantly at FR80. In addition, five of eight subjects tested with quipazine failed to complete the FR80 in 15 min. In subsequent experiments, the breaking point, here defined as the number of LSD-appropriate responses prior to emission of ten responses on the saline-appropriate lever, was determined for LSD and for quipazine. Mean values (N=12) for LSD and quipazine were 161±28 and 65±19, respectively.
Article PDF
Avoid common mistakes on your manuscript.
References
Hirschhorn ID, Winter JC (1971) Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacologia 22:64–71
Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943–944
Hodos W (1965) Motivational properties of long durations of rewarding brain stimulation. J Comp Physiol Psychol 59:219–224
Kuhn DM, White FJ, Appel JB (1978) The discriminative stimulus properties of LSD: Mechanisms of action. Neuropharmacol 17:257–262
Winter JC (1979) Quipazine-induced stimulus control in the rat. Psychopharmacology 60:265–269
Winter JC (1980) Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and SCH12,679, in rats trained with LSD as a discriminative stimulus. Psychopharmacology 68:159–162
Yanagita T (1973) An experimental framework for evaluation of dependence lability of various types of drugs in monkeys. Bull Narc 1:25–57
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winter, J.C. Drug-induced stimulus control and the concept of breaking point: LSD and quipazine. Psychopharmacology 72, 217–218 (1981). https://doi.org/10.1007/BF00431661
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431661